Font Size:
a
A
A
Keyword [large B-cell lymphoma]
Result: 121 - 140 | Page: 7 of 10
121.
The Significance Of CD44ICD In Difuse Large B-cell Lymphoma Cell Line SUDHL2and The Preliminary Study On The Mechanism
122.
Study On Clincopathological Features And Microvessel Density Of Human Primary Central Nervous System Diffuse Large B Cell Lymphoma
123.
Research On The Prognostic Factors Of Cases With Opposite Results According To Immunophenotypic Classifications In Diffuse Large B-cell Lymphoma
124.
Expression And Clinical Significance Of CD40in Diffuse Large B-cell Lymphoma
125.
Significance Of MicroRNA-146b-5p In Difeuse Large B-cell Lymphoma And Its Relation To Risk Assessment
126.
The Investigation Of MYC Gene Aberration In Diffuse Large B-cell Lymphomas
127.
Clinic Analysis Of A Case Of Primary Diffuse Large B Cell Lymphoma Of Bone With Hemophagocytic Symdrome
128.
A Case Report Of Diffuse Large B-cell Lymphoma With Hemophagocytic Syndrome And Literature Review
129.
A Case Report Of Post-transplant Lymphoproliferative Disorder And Literature Review
130.
Case Analysis Of Elderly Patients With Refractory Diffuse Large B-cell Lymphoma And Literature Review
131.
Analysis Of The Prognosis Of159Cases With Diffuse Large B Cell Lymphoma(DLBCL)
132.
Study On Rituximab Plus Chemotherpay Onpatients With Diffuse Large B-cell Lymphoma
133.
Relationship Between Lymphopenia Following The Completion Of R-CHOP Chemotherapy And Relapse In Patients With Diffuse Large B Cell
134.
The Expression Of FOXP3and Its Prognosis In Diffuse Large B Cell Lymphoma
135.
HENT1、NF-κB Expression In Diffuse Large B Cell Lymphoma And Its Significance
136.
The Correlation Analysis Of Prognostic And Immunophenotype Between Uygur And Han Race In Diffuse Large B-cell Lymphoma
137.
Correlation Between The Clinical Features And Immunological Subtypes Of Diffuse Large B-cell Lymphoma In Uyghur And Han Patients
138.
Clinical Significance Of Absolute Lymphocyte Count In Extranodal Diffuse Large B Cell Lymphoma
139.
Combined Measurement Of Immunophenotype And International Staging System In Multiple Myeloma Defines Patients With Good Or Poor Prognosis
140.
Clinical Analysis Of49Patients With Primary Mediastinal Large B Cell Lymphoma
<<First
<Prev
Next>
Last>>
Jump to